Xenon Pharmaceuticals Inc. (FRA:XP0)

Germany flag Germany · Delayed Price · Currency is EUR
34.80
+0.20 (0.58%)
At close: Jan 30, 2026
-8.90%
Market Cap2.67B -10.3%
Revenue (ttm)6.39M
Net Income-261.09M
EPS-3.31
Shares Outn/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volume13
Open34.80
Previous Close34.60
Day's Range34.80 - 34.80
52-Week Range25.00 - 39.00
Betan/a
RSI46.13
Earnings DateFeb 27, 2026

About Xenon Pharmaceuticals

Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, engages in the discovery, development, and delivery of therapeutics to treat patients with neurological and psychiatric disorders in Canada. Its product candidates include Azetukalner, a selective Kv7 potassium channel opener in Phase 3 clinical development for the treatment of epilepsy, including focal onset seizures, and primary generalized tonic-clonic seizures, as well as neuropsychiatric disorders, such as major depressive disorder and bipolar depression. The com... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1996
Employees 327
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol XP0
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements